Open access
83
Views
0
CrossRef citations to date
0
Altmetric
Review
Nanomedicines in the treatment of chronic hepatitis C – focus on pegylated interferon alpha-2a
Thea Thomas1 Specialist Registrar in Gastroenterology, University College London Hospital NHS Trust, London;
& Graham Foster2 Queen Marys School of Medicine, Barts and The London NHS Trust, LondonCorrespondence[email protected]
Pages 19-24
|
Published online: 09 Oct 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.